AAA517 clinical trials

A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC

This study looks into a new treatment (AAA617) for a type of prostate cancer that has stopped responding to standard hormone therapy. It also checks if combining AAA617 with existing hormone-blocking drugs works better.